Skip to main content

Hill, Mitch C.'s Form 4 filing

Inari Medical, Inc. (NARI) · filed Sep 13, 2024

Accession no.
0001127602-24-023899
Filed
Sep 13, 2024, 4:35 PM ET
Trade date
Sep 12, 2024
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $135.4K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hill, Mitch C.CIK 0001644989Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 12, 2024Common StockMOption exerciseAcquired+3,000$0.457+$1,371182,600Direct
Sep 12, 2024Common StockSSaleDisposed−1,609$44.38−$71,407.42180,991Direct
Sep 12, 2024Common StockSSaleDisposed−891$45.80−$40,807.8180,100Direct
Sep 12, 2024Common StockSSaleDisposed−500$46.34−$23,170179,600Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 12, 2024Common StockMOption exerciseDisposed−3,000$0.00$058,477Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)